Athira pharma announces promotion of kevin church, ph.d., to chief scientific officer

Bothell, wash., jan. 31, 2023 (globe newswire) -- athira pharma, inc. (nasdaq: atha), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced the promotion of kevin church, ph.d., to chief scientific officer.
ATHA Ratings Summary
ATHA Quant Ranking